ArticlePharmacoepidemiology and drug safety2020

Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?

Jim Slattery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.